Research.Patient.info
Medullary Thyroid Cancer research hub
2 indexed studies · 0 currently recruiting
- active not recruitingPHASE1, PHASE2
A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors
This study looks at a new medicine called Selpercatinib for children and young people (ages 6 months to 21 years) with certain advanced solid tumours or brain tumours. It's for those whose tumours have a specific genetic change (called RET alteration).
United States · Australia · Canada - active not recruitingPHASE2
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
This study looks at a drug called entrectinib for different types of advanced cancer. It focuses on cancers with specific genetic changes (NTRK, ROS1, or ALK gene fusions). Researchers want to see if entrectinib can help treat these cancers.
United States · Australia · Belgium